Toggle navigation
LOGO
About TTY
About TTY
Strategic Deployment
About Strategic Deployment
Global Operations
TTY Group
Management
Corporate Executives
Successor Project
Organization
Collaboration and Services
Licensing
Contract Development Manufacturing
PIC/S GMP Business Service
CRO Service
Distribution
Newsroom
Technology Development
Technology Development
Liposomes
Introduction
Pipeline
Microspheres
Introduction
Pipeline
Conventional Products
Introduction
Dosage Form
Formulation Capabilities
Formulation Development
Analytical Development
Process Development
Animal Studies
Functional Excipents
GMP Manufacturing
CMC Preparation
CRO Technology
Manufacturing
Manufacturing
Clinical Supply
Cytotoxic Products
Non-cytotoxic Products
Products
Products
Oncology
Products
Clinical Research Center
Translational Research Center
About TOT BU
Anti-Infection
Products
About TIT BU
Healthcare
Products
About THT BU
Investors
Investors
Investor Conference
Financials
Monthly Revenues
Financial Statements
Annual Report
Shareholder Services
Dividends
Shareholder's Meeting
List of Major Shareholders
Corporate Governance
Board of Directors
Sustainable Development Committee
Audit Committee
Remuneration Committee
Major Corporate Policies
Internal Audit
IP Management
Information Security
Careers
Careers
Philosophy
Salaries & Benefits
Attractive salary
Excellent benefits
Amicable environment
Positive activities
TTY Seeds
TTY University
New Comer Socialization
Talent Development Program (TDP)
Join TTY
Professional challenges
Recruitment process
Transportation ways
Industry Academy Cooperation
Sustainability
Sustainability
CSR Reports
Governance
Environmental
Energy & GHG Emission
Water Management
Air Pollution Control
Waste Management
Toxicity Management
TTY Actions
Social
Cancer Cares
Love for Society
TTY Friendship
Awards
Employee Care
Salary & Benefits
Comprehensive Training
Occupational Safety & Health
Covid-19 Prevention
Supplier
En /
Es /
繁中
Previous
Next
Newsroom
2021/9/10
Announcement of TTY Biopharm's unaudited income information in August 2021
Announcement of TTY Biopharms unaudited income information in August 2021
2021/8/11
Announcement of TTY Biopharm's unaudited income information in July 2021
2021/8/5
Announcement of The Consolidated Financial Report for The 2nd Quarter of 2021
2021/7/12
Announcement of TTY Biopharm's unaudited income information in June 2021
2021/6/10
Announcement of TTY Biopharm's unaudited income information in May 2021
+More
TTY Group
Financials
Monthly Revenues
Financial Statements
Annual Reports
Collaboration and Service
Licensing
Contract Design Manufacturing
PIC/S GMP Business Service
CRO Service
Distribution
Sustainability
Promotion Center
Environmental
Social
Employee Care
Governance
Supplier
Stakeholder
^
TOP
